Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma. | J Oncol | 2023 | 36761433 | PubTator, text mining | PubMed |
| Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry. | Cancer Metastasis Rev | 2023 | 36754910 | PubTator, text mining | PubMed |
| The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes. | Front Immunol | 2023 | 36733487 | PubTator, text mining | PubMed |
| Propolis anti-inflammatory effects on MAGE-1 and retinoic acid-treated dendritic cells and on Th1 and T regulatory cells. | J Venom Anim Toxins Incl Trop Dis | 2023 | 36721426 | PubTator, text mining | PubMed |
| Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma. | J Blood Med | 2023 | 36712581 | PubTator, text mining | PubMed |
| Prognostic indices for peripheral T-cell lymphoma - not otherwise specified and adult T-cell leukemia/lymphoma: From past to future. | J Clin Exp Hematop | 2023 | 36709976 | PubTator, text mining | PubMed |
| Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease. | JHEP Rep | 2023 | 36687470 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer. | J Exp Clin Cancer Res | 2023 | 36683048 | PubTator, text mining | PubMed |
| Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review. | Vaccines (Basel) | 2023 | 36679991 | PubTator, text mining | PubMed |
| A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients. | Int J Mol Sci | 2023 | 36675190 | PubTator, text mining | PubMed |
| Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients. | Diagnostics (Basel) | 2023 | 36673136 | PubTator, text mining | PubMed |
| Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma. | Haematologica | 2023 | 36632739 | PubTator, text mining | PubMed |
| The Immunological Conundrum of Endogenous Retroelements. | Annu Rev Immunol | 2023 | 36630597 | PubTator, text mining | PubMed |
| Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. | Nat Genet | 2023 | 36624340 | PubTator, text mining | PubMed |
| Molecular profiling of EBV associated diffuse large B-cell lymphoma. | Leukemia | 2023 | 36604606 | PubTator, text mining | PubMed |
| Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors. | Proc Natl Acad Sci U S A | 2023 | 36598945 | PubTator, text mining | PubMed |
| Targeted surface marker screening on neuronal structures in the human choroid. | Exp Eye Res | 2023 | 36586549 | PubTator, text mining | PubMed |
| CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. | Immunity | 2023 | 36580918 | PubTator, text mining | PubMed |
| A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance. | Eur Urol Focus | 2023 | 36517408 | PubTator, text mining | PubMed |
| Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination. | iScience | 2023 | 36507223 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=21